As a sponsor for the third annual OneMedForum New York to be held July 11-12, BDO Life Sciences will host a special workshop to discuss compensation practices at life sciences companies.
Zymeworks Inc. is a privately held biotechnology company committed to developing best-in-class protein therapeutics for the treatment of cancer.
The mounting health literacy dilemmas lead to the development of Smart Screen® which is designed to improve the delivery of patient education at the point of care.
Using the internet and crowdfunding, the firm is developing an investment partnership and they’re now raising 60 million Euros.
Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE:PLTR) recently announced that a seven year-old girl suffering from an aplastic bone marrow whose condition was rapidly deteriorating is now experiencing a reversal of her condition.
Gerry DiFiore, partnered with the global law firm of Reed Smith is specialized in securities law on emerging growth companies. He recently co-authored a paper on the Jobs Act.
Biovest has developed a patient-specific, cancer vaccine, BiovaxID®, with three clinical trials completed.
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for antiviral therapy.
Synthetic Biologics (SYN) is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses.
The company’s lead product, SwiftPayMD is a recently launched mobile app for iPad and iPhone that helps doctors work more efficiently when seeing patients at the hospital.
Copyright © 2025 | WordPress Theme by MH Themes